Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Hepatic Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01431833
What this trial is testing

A PK and Safety Study in Subjects With Hepatic Impairment

Who this might be right for
Hepatic Impairment
Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 32
Early research (Phase 1)Study completedNCT02120547
What this trial is testing

Phase 1 Study of Multiple-Dose Pharmacokinetics of Cenicriviroc in Subjects With Mild and Moderate Hepatic Impairment

Who this might be right for
Liver Insufficiency
Tobira Therapeutics, Inc. 31
Early research (Phase 1)Study completedNCT06952634
What this trial is testing

An Investigational Study of ESK-001 in Participants With Normal Liver Function and Participants With Mild, Moderate, and Severe Liver Damage

Who this might be right for
Hepatic Impairment
Alumis Inc 32
Early research (Phase 1)Study completedNCT06004934
What this trial is testing

Evaluate the Pharmacokinetics of Avacopan (CCX168) in Participants With Mild or Moderate Hepatic Impairment

Who this might be right for
Hepatic Impairment
Amgen 24
Early research (Phase 1)Study completedNCT03289234
What this trial is testing

Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Hepatic Impairment

Who this might be right for
Hepatic ImpairmentHealthy
Shionogi 22
Early research (Phase 1)Study completedNCT02171832
What this trial is testing

Single Dose of BI 1744 CL in Patients With Mild and Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function

Who this might be right for
HealthyLiver Diseases
Boehringer Ingelheim 32
Early research (Phase 1)Study completedNCT00416702
What this trial is testing

Safety and Pharmacokinetics of Indacaterol in Healthy Subjects and Those With Impaired Liver Function

Who this might be right for
Hepatic Insufficiency
Novartis 32
Early research (Phase 1)Looking for participantsNCT07751250
What this trial is testing

Comparative PK Assessment Study of Casdatifan in Moderate Hepatically Impaired Participants Versus Matched Participants With Normal Hepatic Function

Who this might be right for
Healthy ParticipantsHepatic Impairment
Arcus Biosciences, Inc. 16
Early research (Phase 1)Study completedNCT04116476
What this trial is testing

Study to Assess Pharmacokinetics, Safety, and Tolerability of MT-7117 in Subjects With Normal and Impaired Hepatic Function

Who this might be right for
Mild and Moderate Hepatic Impairment
Tanabe Pharma America, Inc. 23
Early research (Phase 1)Study completedNCT02859207
What this trial is testing

Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects

Who this might be right for
Early Alzheimer's Disease
Eisai Inc. 32
Early research (Phase 1)Study completedNCT03341884
What this trial is testing

Ipatasertib in Participants With Mild, Moderate or Severe Hepatic Impairment Compared to Healthy Participants

Who this might be right for
Hepatic Insufficiency
Genentech, Inc. 29
Early research (Phase 1)Study completedNCT05409911
What this trial is testing

Assess S-217622 in Participants With Mild and Moderate Hepatic Impairment and Healthy Control Participants

Who this might be right for
Hepatic Impairment
Shionogi 25
Early research (Phase 1)Study completedNCT00698464
What this trial is testing

Pharmacokinetics and Safety of Single Subcutaneous Pasireotide (SOM230) in Subjects With Varying Degrees of Hepatic Function

Who this might be right for
Hepatic CirrhosisAlcoholism
Novartis Pharmaceuticals 34
Early research (Phase 1)Study completedNCT05674474
What this trial is testing

Vorasidenib in Participants With Moderate or Mild Hepatic Impairment and Matched Participants With Normal Hepatic Function

Who this might be right for
Hepatic Impairment
Institut de Recherches Internationales Servier 16
Early research (Phase 1)Ended earlyNCT02050815
What this trial is testing

MEK162 in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic Function

Who this might be right for
Hepatic Impairment
Array Biopharma, now a wholly owned subsidiary of Pfizer 27
Early research (Phase 1)Not Yet RecruitingNCT07550634
What this trial is testing

Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic Impairment

Who this might be right for
Hepatic Impairment (Mild and Moderate, Child-Pugh Class A and B)Hepatic Insufficiency (MeSH ID: D048550)
MindRank AI Ltd 32
Early research (Phase 1)Looking for participantsNCT06962332
What this trial is testing

Pharmacokinetics (PK) and Safety of Zanzalintinib in Participants With Moderate Hepatic Impairment (HI)

Who this might be right for
Hepatic ImpairmentModerate Hepatic Impairment
Exelixis 20
Early research (Phase 1)Study completedNCT06444204
What this trial is testing

Evaluate the Effect of Mild and Moderate Hepatic Impairment on the Single-Dose Pharmacokinetics of Rilzabrutinib (PRN1008)

Who this might be right for
Hepatic Function AbnormalHealthy Volunteers
Principia Biopharma, a Sanofi Company 29
Early research (Phase 1)Study completedNCT02571816
What this trial is testing

Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of ASP2215

Who this might be right for
Hepatic ImpairmentHealthy
Astellas Pharma Global Development, Inc. 24
Early research (Phase 1)Study completedNCT06535399
What this trial is testing

Study to Assess Drug Levels and Safety of Golcadomide (BMS-986369) in Healthy Participants and Participants With Different Degrees of Hepatic Impairment

Who this might be right for
Hepatic ImpairmentHealthy Volunteers
Celgene 29
Next Page